Rankings
▼
Calendar
ALT FY 2025 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena
ALT
Altimmune, Inc.
$353M
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$41,000
+105.0% YoY
Gross Profit
$0
0.0% margin
Operating Income
-$94M
-230461.0% margin
Net Income
-$88M
-214861.0% margin
EPS (Diluted)
$-1.00
Cash Flow
Operating Cash Flow
-$68M
Free Cash Flow
-$68M
Stock-Based Comp.
$16M
Balance Sheet
Total Assets
$280M
Total Liabilities
$55M
Stockholders' Equity
$225M
Cash & Equivalents
$44M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$41,000
$20,000
+105.0%
Gross Profit
$0
$20,000
-100.0%
Operating Income
-$94M
-$103M
+8.4%
Net Income
-$88M
-$95M
+7.3%
← Q4 2024
All Quarters
Q1 2025 →